Publications by authors named "Mary N Carrington"

Article Synopsis
  • The study explores the impact of very early antiretroviral therapy (ART) on infants born with HIV-1, aiming to limit HIV reservoirs for potential treatment-free remission.
  • Conducted across 30 clinics in 11 countries, infants were categorized into two cohorts based on maternal HIV treatment, starting ART within 48 hours of birth to monitor virological suppression and safety outcomes.
  • Results from 440 infants (54 with confirmed HIV-1) showed that a significant majority received effective study ART, indicating early intervention may positively affect health outcomes in these infants.
View Article and Find Full Text PDF

CD4 T cells are central to long-term immunity against viruses through the functions of T helper 1 (T1) and T follicular helper (T) cell subsets. To better understand the role of these subsets in coronavirus disease 2019 (COVID-19) immunity, we conducted a longitudinal study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific CD4 T cell and antibody responses in convalescent individuals who seroconverted during the first wave of the pandemic in Boston, MA, USA, across a range of COVID-19 disease severities. Analyses of spike (S) and nucleocapsid (N) epitope-specific CD4 T cells using peptide and major histocompatibility complex class II (pMHCII) tetramers demonstrated expanded populations of T cells recognizing the different SARS-CoV-2 epitopes in most individuals compared with prepandemic controls.

View Article and Find Full Text PDF
Article Synopsis
  • Ebola virus persistence in survivors' semen may contribute to recent outbreaks in places like Guinea and the Democratic Republic of Congo, prompting this study of 131 male EVD survivors in Liberia.
  • The study aimed to categorize participants as "early clearers" or "late clearers" based on their EBOV detection in semen, while also collecting clinical history and conducting medical examinations.
  • Findings indicated that older age, milder initial symptoms, and specific immune markers (IgG3 levels and HLA-C*03:04 allele) were linked to longer EBOV persistence in semen, suggesting potential connections to other areas in the body where the virus might hide.
View Article and Find Full Text PDF
Article Synopsis
  • * Recent research has identified specific genetic risk factors (alleles) for drug-induced SJS/TEN and shown that screening can help lower its incidence.
  • * Despite these advancements, there is still a significant need for further understanding and preventive measures for this serious drug complication.
View Article and Find Full Text PDF

A major challenge for the development of an effective vaccine against tuberculosis (TB) is that the attributes of protective CD4 T cell responses are still elusive for human TB. Infection with HIV type 1 is a major risk factor for TB, and a better understanding of HIV-induced alterations of -specific CD4 T cells that leads to failed host resistance may provide insight into protective T cell immunity to TB. A total of 86 participants from a TB-endemic setting, either HIV-infected or uninfected and with latent or active TB (aTB), were screened using -specific MHC class II tetramers.

View Article and Find Full Text PDF

Objective: Long-acting rilpivirine is a candidate for preexposure prophylaxis (PrEP) for prevention of HIV-1 infection. However, rilpivirine resistance mutations at reverse transcriptase codon 138 (E138X) occur naturally in a minority of HIV-1-infected persons; in particular those expressing human leukocyte antigen (HLA)-B18 where reverse transcriptase-E138X arises as an immune escape mutation. We investigate the global prevalence, B18-linkage and replicative cost of reverse transcriptase-E138X and its regional implications for rilpivirine PrEP.

View Article and Find Full Text PDF

Previous genome-wide association studies (GWAS) of HIV-1-infected populations have been underpowered to detect common variants with moderate impact on disease outcome and have not assessed the phenotypic variance explained by genome-wide additive effects. By combining the majority of available genome-wide genotyping data in HIV-infected populations, we tested for association between ∼8 million variants and viral load (HIV RNA copies per milliliter of plasma) in 6,315 individuals of European ancestry. The strongest signal of association was observed in the HLA class I region that was fully explained by independent effects mapping to five variable amino acid positions in the peptide binding grooves of the HLA-B and HLA-A proteins.

View Article and Find Full Text PDF

Genome-wide association studies of the related chronic inflammatory bowel diseases (IBD) known as Crohn's disease and ulcerative colitis have shown strong evidence of association to the major histocompatibility complex (MHC). This region encodes a large number of immunological candidates, including the antigen-presenting classical human leukocyte antigen (HLA) molecules. Studies in IBD have indicated that multiple independent associations exist at HLA and non-HLA genes, but they have lacked the statistical power to define the architecture of association and causal alleles.

View Article and Find Full Text PDF

Recent studies suggest that innate immune responses by natural killer (NK) cells play a significant role in restricting human immunodeficiency virus type-1 (HIV-1) pathogenesis. Our aim was to characterize changes in NK cells associated with HIV-1 clade C disease progression. Here we used multiparametric flow cytometry (LSRII) to quantify phenotype and function of NK cells in a cross-sectional analysis of cryopreserved blood samples from a cohort of 41 chronically HIV-1-infected, treatment-naive adult South Africans.

View Article and Find Full Text PDF